Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Novo Nordisk boosts app armory with hemophilia gaming, blood disorder tracking apps

November 27, 2012 11:42 am by | 0 Comments

Novo Nordisk has launched its ninth app to help hemophiliacs and caregivers track bleeding events and medications. The Danish drug developer has been deepening its blood disorder diagnostic tools aimed at healthcare professionals as well as consumer-friendly apps for tracking and gaming.

Novo Nordisk’s HemaGo app is designed so that more than one family member can use the tool to monitor the genetic bleeding disorder. HemaGo users can track medications and set reminders for treatment or doctor’s appointments. They can also record factor usage and the reason for the infusion; the type, location and duration of bleeding events; and pain scores including the impact of the bleeding episode on the patient’s participation in work or school, according to a company statement.  The company claims it is the first to help individuals track almost every aspect of living with a bleeding disorder, regardless of their medication or disorder.

A spokeswoman for the Princeton, New Jersey-based company said its gaming app coming out soon will be an engagement tool rolled into an asteroid blasting game.

“We are about to launch the Novo Rocket Trooper Gaming app. This game takes the patient through a maze of asteroids and has them answer disease state information questions giving them additional turbo boosts and force fields. The objective of the game is to provide a fun way for patients to learn about hemophilia and to provide a distraction for young patients while they are receiving their infusions.”

Advertisement

Its Coags Uncomplicated app is designed as a tool to help doctors diagnose coagulation disorders.

An estimated 20,000 people in the U.S. have hemophilia with 500 new cases diagnosed each year, according to the Centers for Disease Control and Prevention.

There has been a jump in the number of hemophilia apps in the past couple of years with apps from CSL Behring, Baxter Healthcare and Pfizer available at the iTunes Store.

Bayer HealthCare Pharmaceuticals’ FactorTrack, released in June 2010, was the first to help hemophiliacs track their bleeding events, infusions and doses as well as alerts for infusions. It released an updated version of the app last month. CSL Behring also launched an app, HeliTrax, for people with hemophilia A in 2010, along with an updated version in August.  Michael Schultz, the creator of Hemolog in 2010, has since joined Affinity Biotech, a specialty pharmacy that provides home care for people affected by bleeding disorders.

The mobile health app market is expected to soar to nearly $12 billion by 2015.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Stephanie Baum

By Stephanie Baum

Stephanie Baum is the East Coast Innovation Reporter for MedCityNews.com. She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.
Visit website | More posts by Author

0 comments